TG Therapeutics News

HC Wainwright & Co. : TG Therapeutics (TGTX.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $45.00 to $49.00.

Zhitong FinanceMay 2 12:30

TG Therapeutics Analyst Ratings

BenzingaMay 2 08:03

Ladenburg Thalmann Maintains Buy on TG Therapeutics, Raises Price Target to $40

BenzingaMay 2 08:04

Sell Rating on TG Therapeutics: Caution Amid Competitive Threats and Decelerating Prescription Growth

TipRanksMay 2 04:25

Hold Rating on TG Therapeutics Amidst Strong Briumvi Launch and Competitive Market Pressures

TipRanksMay 1 16:35

Briumvi's Market Share Growth and TG Therapeutics' Strong Financial Outlook Justify Buy Rating

TipRanksApr 30 11:45

Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)

TipRanksApr 23 08:38

Komo: The TG Therapeutics (TGTX.US) rating was confirmed and adjusted from an increase in holdings to an increase in holdings rating, with a target price of $25.00.

Zhitong FinanceApr 18 12:31

TG Therapeutics Analyst Ratings

BenzingaApr 18 12:28

Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX)

TipRanksApr 18 08:30

TG Therapeutics Analyst Ratings

BenzingaMar 1 13:20

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)

TipRanksFeb 29 04:40

HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $45 Price Target

BenzingaFeb 28 11:38

Goldman Sachs Sticks to Their Hold Rating for TG Therapeutics (TGTX)

TipRanksFeb 28 11:05

TG Therapeutics: Promising European Expansion and Strong Financial Outlook Justify Buy Rating

TipRanksFeb 26 10:45

Analysts' Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Zoetis (ZTS) and Teladoc (TDOC)

TipRanksFeb 13 08:02

TG Therapeutics Analyst Ratings

BenzingaFeb 5 14:07

B. Riley Adjusts Price Target on TG Therapeutics to $29 From $24, Maintains Buy Rating

MT NewswiresFeb 5 08:05

Buy Rating Affirmed for TG Therapeutics on Strong Briumvi Sales and Favorable Market Dynamics

TipRanksFeb 2 11:45

TG Therapeutics Analyst Ratings

BenzingaJan 11 06:50